Joseph Broderick, MD
Chair, Department of Neurology
University of Cincinnati
Toufic A. Fakhoury, MD
Professor of Neurology
Director, Comprehensive Epilepsy Program
University of Kentucky
Stephen S. Kirzinger, MS, MD
Assistant Professor of Neurology
Director, Multiple Sclerosis Program
University of Louisville
William S. Henderson, FACMPE
Upstate Neurology Consultants, LLP
Albany, NY
Upon completion of this activity, participants will be able to:
- Discuss recently developed stroke and multiple sclerosis treatment regimens.
- Describe the impact of generic medication formulations in treating seizures.
- Outline advances in provision of care.
MedicineThis activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Commonwealth Neurological Society. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Kentucky College of Medicine designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits. Each physician should claim only those hours of credit actually spent in the educational activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
Neurologists, neurosurgeons, PMR, office managers, and nurse practitioners in the Commonwealth of Kentucky with an interest in updates in neurological disease and practice.
Faculty presenters of continuing education programs sponsored by the University of Kentucky College of Medicine are expected to disclose any real or perceived conflict of interest. Copies of faculty disclosures are included in participant program materials or given prior to the lecture.
This activity is jointly sponsored by the University of Kentucky and Commonwealth Neurological Society.
Registration fee is $100 which includes continental breakfast, syllabus and a statement of credit.
A refund, less a $25 processing fee, will be issued if written notice of withdrawal is received by September 26, 2008; refunds will not be allowed after this date. Registration may be transferred to another participant.
The University of Kentucky Pharmacy and Medicine Continuing Education Office reserves the right to cancel or make substitutions in this activity. A full refund will be issued if circumstances warrant cancellation.
Participants will learn about updates in stroke, MS, and epilepsy and how to better manage their clinical practices. This will increase the quality of care in patients with neurological disease in the Commonwealth of Kentucky.